Stem Cells & Differentiation

Stem cells are undifferentiated cells with two defining properties: 1. Self-renewal — they can copy themselves through cell division, maintaining a supply of stem cells 2. Differentiation — they can develop into more specialised cell types Think of a stem cell as a blank template that hasn't yet committed to a job. A muscle cell is forever a muscle cell — it can only divide to make more muscle cells. A stem cell is still undecided — given the right signals, it can become a muscle cell, a liver cell, a neuron, or a blood cell. Stem cells are found throughout the body at all stages of life — from the earliest embryo to adult tissues — though their potency (the range of cell types they can become) decreases with age and specialisation. The body uses stem cells for: - Development — building all 200+ cell types of the body from a single fertilised egg - Maintenance — continuously replenishing cells that wear out (like gut lining cells, which are replaced every 4–5 days, or red blood cells, replaced every ~120 days) - Repair — healing damaged tissue after injury

Stem cells are classified by how many different cell types they can produce — their potency. Totipotent ("total power") Can form ANY cell — body cells AND placental cells. Only the fertilised egg (zygote) and its first few divisions (up to the 8-cell stage) are totipotent. One of these cells, given the right environment, could develop into an entire human being. Pluripotent ("plural power") Can form any cell in the body but NOT placental cells. Embryonic stem cells (ESCs), derived from the inner cell mass of the blastocyst (a ~5-day-old embryo), are pluripotent. They can make any of the 200+ cell types. Multipotent ("multiple power") Can produce several related cell types within a specific lineage, but not cells from other lineages. Example: haematopoietic stem cells (HSCs) in bone marrow can produce all blood cell types (red blood cells, white blood cells, platelets) but cannot become liver cells or neurons. Oligopotent — can produce a few closely related types (e.g. lymphoid progenitor cells → B and T lymphocytes) Unipotent — can only produce one cell type, but still self-renew. Example: muscle satellite cells → skeletal muscle fibres only.

Differentiation is the process by which a less specialised cell becomes a more specialised one. It is one of the most fundamental processes in biology — it is how a single fertilised egg becomes a whole human being with 200+ different cell types. The key insight: Every cell in your body has the SAME DNA. A liver cell and a neuron have identical genetic instructions. What makes them different is not WHAT genes they have, but WHICH genes are switched on or off. This selective gene expression is controlled by: Transcription factors — proteins that bind to specific DNA sequences near genes and switch them on (activate) or off (silence). Different cells express different transcription factors, leading to different protein profiles and different identities. Epigenetic modifications — chemical tags added to DNA or the histone proteins around which DNA is wound. These tags don't change the DNA sequence but change how accessible it is. DNA methylation generally silences genes; histone acetylation generally activates them. "Epigenetic" means "above the genes" — it is heritable gene regulation without changing the underlying genetic code. Cell signalling — neighbouring cells and the surrounding environment send molecular signals (growth factors, morphogens, contact signals through gap junctions) that instruct a stem cell which fate to take. Example: bone morphogenetic proteins (BMPs) push cells towards bone-forming cells; Wnt signals promote gut stem cell maintenance. Once fully differentiated, these patterns are stable — daughter cells of liver cells become liver cells, not neurons.

In 2006, Japanese scientist Shinya Yamanaka made one of the most important medical discoveries of the century: ordinary adult cells (like skin cells) could be reprogrammed back into a pluripotent state — essentially rewinding the clock on differentiation. He did this by introducing just four specific transcription factors (proteins that control gene expression) into adult cells. These four factors — Oct4, Sox2, Klf4, and c-Myc — are now called the Yamanaka factors. This discovery won the 2012 Nobel Prize in Physiology or Medicine. The resulting cells are called induced pluripotent stem cells (iPSCs) because they behave like embryonic stem cells — able to become virtually any cell type — but they are made from ordinary adult cells. Why iPSCs are revolutionary: No embryo needed — bypasses the ethical issues of using human embryos for stem cell research. iPSCs can be made from any adult cell (skin, blood, urine). Patient-specific — make iPSCs from a patient's own cells, differentiate them into the needed cell type, and transplant back. Because they come from the patient's own body, the immune system won't reject them. This is personalised regenerative medicine. Disease-in-a-dish — take iPSCs from a patient with Parkinson's disease, differentiate them into dopamine-producing neurons (the cells that die in Parkinson's), and study the disease in a lab dish. This has already revealed new mechanisms and potential drug targets for conditions including ALS, schizophrenia, and heart disease. Drug testing — test drug safety on human cells derived from iPSCs rather than animal cells — much more predictive of human responses.

Stem cell biology is at the intersection of basic science and transformative medicine. Here is where it is already making a difference — and where it is heading. Current clinical applications: Bone marrow transplants — haematopoietic stem cell transplants are standard treatment for leukaemia, lymphoma, multiple myeloma, severe aplastic anaemia, and some immune deficiency diseases. Tens of thousands are performed annually worldwide. Skin grafting — epidermal stem cells from a small skin biopsy can be cultured to grow large sheets of skin for burn victims. Limbal stem cell transplants — stem cells at the edge of the cornea (limbus) maintain the eye's clear surface. When these are destroyed (by chemical burns), transplanting donor limbal stem cells can restore vision. CAR-T cell therapy — immune cells (T cells) taken from a cancer patient, genetically engineered to recognise and attack the patient's cancer, then returned. A form of cell therapy now approved for some blood cancers. Emerging therapies (clinical trials): - Parkinson's disease — replacing the lost dopamine-producing neurons with iPSC-derived neurons - Macular degeneration — replacing the failing retinal pigment epithelium cells that cause blindness - Type 1 diabetes — generating functional insulin-producing beta cells from iPSCs - Spinal cord injury — encouraging regeneration with stem cell-derived support cells Cancer stem cells: Many tumours contain a small population of cancer stem cells — these are the most resistant to chemotherapy and are thought to drive tumour recurrence after treatment. Understanding and targeting cancer stem cells is a major focus of modern oncology research.